Literature DB >> 23344546

Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.

Donald N Forthal1, Gary Landucci, Bhavna Chohan, Barbra A Richardson, R Scott McClelland, Walter Jaoko, Catherine Blish, Julie Overbaugh.   

Abstract

Previous studies of HIV-infected women with high-risk behavior have indicated that neither neutralizing antibody nor cellular immunity elicited by an initial HIV-1 infection is associated with protection against superinfection with a different HIV-1 strain. Here, we measured antibody-dependent cell-mediated virus inhibition (ADCVI) antibody activity in the plasma of 12 superinfected cases and 36 singly infected matched controls against 2 heterologous viruses. We found no association between plasma ADCVI activity and superinfection status. ADCVI antibody activity against heterologous virus elicited by the original infection may not contribute to preventing a superinfecting HIV-1.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23344546      PMCID： PMC3625514          DOI： 10.1097/QAI.0b013e3182874d41

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


  19 in total

1.  Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.

Authors:  D N Forthal; G Landucci; B Keenan
Journal:  AIDS Res Hum Retroviruses       Date:  2001-04-10       Impact factor: 2.205

2.  HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.

Authors:  Marcus Altfeld; Todd M Allen; Xu G Yu; Mary N Johnston; Deepak Agrawal; Bette T Korber; David C Montefiori; David H O'Connor; Ben T Davis; Paul K Lee; Erica L Maier; Jason Harlow; Philip J R Goulder; Christian Brander; Eric S Rosenberg; Bruce D Walker
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

3.  No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate.

Authors:  Stephanie Rainwater; Shannon DeVange; Manish Sagar; J Ndinya-Achola; Kishorchandra Mandaliya; Joan K Kreiss; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2005-12       Impact factor: 2.205

4.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.

Authors:  Davey M Smith; Matthew C Strain; Simon D W Frost; Satish K Pillai; Joseph K Wong; Terri Wrin; Yang Liu; Christos J Petropolous; Eric S Daar; Susan J Little; Douglas D Richman
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  Fc receptor but not complement binding is important in antibody protection against HIV.

Authors:  Ann J Hessell; Lars Hangartner; Meredith Hunter; Carin E G Havenith; Frank J Beurskens; Joost M Bakker; Caroline M S Lanigan; Gary Landucci; Donald N Forthal; Paul W H I Parren; Preston A Marx; Dennis R Burton
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

6.  Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype.

Authors:  Bhavna Chohan; Ludo Lavreys; Stephanie M J Rainwater; Julie Overbaugh
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients.

Authors:  D N Forthal; G Landucci; R Haubrich; B Keenan; B D Kuppermann; J G Tilles; J Kaplan
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

8.  Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate.

Authors:  Donald N Forthal; Peter B Gilbert; Gary Landucci; Tran Phan
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.

Authors:  Debby Basu; Colleen S Kraft; Megan K Murphy; Patricia J Campbell; Tianwei Yu; Peter T Hraber; Carmela Irene; Abraham Pinter; Elwyn Chomba; Joseph Mulenga; William Kilembe; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  Retrovirology       Date:  2012-09-20       Impact factor: 4.602

10.  Chronic HIV-1 infection frequently fails to protect against superinfection.

Authors:  Anne Piantadosi; Bhavna Chohan; Vrasha Chohan; R Scott McClelland; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823
View more
  16 in total

Review 1.  Antibody-dependent cellular cytotoxicity in HIV infection.

Authors:  Donald N Forthal; Andrés Finzi
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 2.  Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.

Authors:  Yang Gao; Wen Tian; Xiaoxu Han; Feng Gao
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

3.  Reduced frequency of HIV superinfection in a high-risk cohort in Zambia.

Authors:  Evonne Woodson; Debby Basu; Hope Olszewski; Jill Gilmour; Ilene Brill; William Kilembe; Susan Allen; Eric Hunter
Journal:  Virology       Date:  2019-06-15       Impact factor: 3.616

4.  A critical question for HIV vaccine development: which antibodies to induce?

Authors:  Susan Zolla-Pazner
Journal:  Science       Date:  2014-07-11       Impact factor: 47.728

5.  Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.

Authors:  Debby Basu; Peng Xiao; Zachary Ende; Alfred Bere; William J Britt; Joseph Mulenga; William Kilembe; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

Review 6.  New paradigms for functional HIV-specific nonneutralizing antibodies.

Authors:  Don Forthal; Thomas J Hope; Galit Alter
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

Review 7.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

8.  Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine Odem-Davis; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.

Authors:  Keshet Ronen; Connor O McCoy; Frederick A Matsen; David F Boyd; Sandra Emery; Katherine Odem-Davis; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Barbra A Richardson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

Review 10.  Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response.

Authors:  Ecem Saygili; Ece Yildiz-Ozturk; Macauley J Green; Amir M Ghaemmaghami; Ozlem Yesil-Celiktas
Journal:  Biomicrofluidics       Date:  2021-03-23       Impact factor: 2.800
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.